Iceland· IS-EU/1/19/1392/001
Ervebo
A ebola-impfstoffe product containing recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the zaire ebolavirus (strain kikwit-1995) surface glycoprotein, registered in Iceland by Merck Sharp & Dohme B.V.*. The same ATC class is registered in 9 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Ebola-impfstoffe is registered in 9 of 19 countries.
Countries holding a registration under ATC J07BX02 (ebola-impfstoffe), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Ebola-impfstoffe · ATC J07BX02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Recombinant Vesicular Stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the Zaire ebolavirus (strain Kikwit-1995) surface glycoprotein
- Manufacturer
- Merck Sharp & Dohme B.V.*
- Country
- Iceland (IS)
- ATC code
- J07BX02
- ATC class
- Ebola-Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX02
Ebola-impfstoffe, as other registers publish it.
- FinlandErveboMerck Sharp & Dohme B.V.
- DenmarkErveboMerck Sharp & Dohme B.V.
- PolandErveboMerck Sharp & Dohme B.V.
- BelgiumErveboMerck Sharp & Dohme
- CzechiaERVEBOMerck Sharp & Dohme B.V., Haarlem
- IrelandErvebo solution for injectionMerck Sharp & Dohme BV,
- SwitzerlandErvebo, InjektionslösungMSD Merck Sharp & Dohme AG
- NetherlandsErvebo, oplossing voor injectieMerck Sharp & Dohme B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f56bb1a2-7ca7-45a3-9c76-5031c9918447 GET /v1/drugs/f56bb1a2-7ca7-45a3-9c76-5031c9918447?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "J07BX02",
"marketed": false,
"strength": null,
"ma_number": "EU/1/19/1392/001",
"substance": "Recombinant Vesicular Stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the Zaire ebolavirus (strain Kikwit-1995) surface glycoprotein",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í smitsjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "43780"
}See everything about ebola-impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.